Biggest News Aggregation in the World
📰 Sue Stuart News

Page 2 - Sue Stuart News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Sue Stuart. Real-time updates on events, politics, business and more.

Investegate |Synairgen plc Announcements | Synairgen plc: Inclusion in US ACTIV-2 trial

About Synairgen  Synairgen is a clinical-stage respiratory drug discovery and development company founded by University of Southampton Professors Sir Stephen Holgate, Donna Davies and Ratko Djukanovic. Synairgen is currently fully focused on progressing its inhaled interferon beta1a  broad spectrum antiviral drug as an effective treatment for people suffering with COVID-19 infection. Synairgens differentiating human biology BioBank platform and world-renowned international...
United Kingdom Olivia Manser Geoff Nash Richard Marsden John Ward Donna Davies

Emergex Vaccines signs Collaboration Agreement with Brazil's Bio-Manguinhos/Fiocruz for the Development of a COVID-19 Vaccine - Brazil Business Today

PRESS RELEASE Emergex Vaccines signs Collaboration Agreement with Brazil’s Bio-Manguinhos/Fiocruz for the Development of a COVID-19 Vaccine Agreement provides a framework for future clinical trials, manufacturing, sales and marketing, and distribution within the National Health Service of Brazil Bio-Manguinhos, is a world leader in vaccine development and manufacturing and one of the productive units of Fiocruz, one of the worlds most respected public health research institutions Abingdon, ...
United States Rio De Janeiro Estado Do Rio Oswaldo Cruz Rio Grande Do Sul United Kingdom

Emergex Vaccines signs Collaboration Agreement with Brazil's Bio-Manguinhos/Fiocruz for the Development of a COVID-19 Vaccine

News Category Global Banking & Finance Reviews Emergex Vaccines signs Collaboration Agreement with Brazil’s Bio-Manguinhos/Fiocruz for the Development of a COVID-19 Vaccine PRESS RELEASE Emergex Vaccines signs Collaboration Agreement with Brazil’s Bio-Manguinhos/Fiocruz for the Development of a COVID-19 Vaccine Agreement provides a framework for future clinical trials, manufacturing, sales and marketing, and distribution within the National Health Service of Brazil Bio-Manguinhos, is a wor...
United States Rio De Janeiro Estado Do Rio Oswaldo Cruz Rio Grande Do Sul United Kingdom

Synairgen plc: COVID-19 Clinical Programme Update

Synairgen plc: COVID-19 Clinical Programme Update Phase III trial design adapted which will expedite results Phase III trial to commence dosing in UK imminently Southampton, UK - 18 December 2020: Synairgen plc (LSE: SNG), the respiratory drug discovery and development company, today announces updates to the Companys Phase III trial design evaluating SNG001 as a treatment for patients with COVID-19 and positive progress on the regulatory path. Update to Phase III trial (SG018) protocol in COV...
United Kingdom Olivia Manser Geoff Nash Richard Marsden John Ward Donna Davies

Investegate |Vectura Group plc Announcements | Vectura Group plc: $11m milestone on US FDA Generic Advair approval

Vectura Group plc Elizabeth Knowles - VP Investor Relations                         +44 (0)7767 160 565   Mary-Jane Elliott / Sue Stuart / David Daley   About Vectura Vectura is a provider of innovative inhaled drug delivery solutions that enable partners and customers to bring their medicines to patients. With differentiated proprietary technology and pharmaceutical development expertise, Vectura is one of the few companies globally with the d...
United Kingdom United States Glaxosmithkline Advair Diskus Stuart David Daley David Ginivan Advair Diskus

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science